Sell signal in its 9th week
Kyverna Therapeutics slips 1.5% as sellers retake control after the pause
Sell signal in its 9th week
Our view last week
Kyverna Therapeutics' decline is pausing: after last week's 12.2% plunge, the week just closed was essentially flat, with 63% of volume swinging back to the buy side and a double bottom holding firm in the 7.1-7.2 area. The picture stays technically neutral, with seller dominance clearly fading; the short, comfortably ahead in recent weeks, is back near breakeven.
This week's summary
Kyverna Therapeutics' pause lasts just one week. After the past few days of calm, sellers are back in charge: 72% of volume swings to the sell side, up from 63% on the buy side the week before, and the distribution phase gets sharper. The weekly signal stays bearish, with the trend's push losing a bit of conviction. The short, back near breakeven a week ago, regains ground.
IQS Phase
84
in tension / maturity
Signal Strength
19
decline starting to make lower lows
Sizing
MINIMUM
Ranking
#55 / 138
US stocks
Trade P&L %
+2.28%
from signal to date, no stop loss
Rank position
ranks 55th among the 138 sell signals for US stocks in our ranking, with a signal strength of 19 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -0.01% · monthly +1.89%
KYTX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content